newsfilter
← Latest News
GlobeNewswire·

AVEO Oncology Highlights Recent Progress and 2022 Outlook

BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company, today highlighted its recent progress and outlook for 2022. "I am proud of the entire AVEO team this ye